Skip to main content
main-content

Expert opinion

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.


Concise and thought-provoking commentary, opinion and analysis from leading rheumatology experts.

The ongoing evolution of remission maintenance strategies for granulomatosis with polyangiitis

Person taking pills

Eric J Gapud and Philip Seo summarize the key milestones in management of severe granulomatosis with polyangiitis, and evaluate the possibility of long-term reduced intensity or drug-free remission for some patients.

Audits on gout management: Far from excellence, but working on it

Doctor auditing medication (symbolic image with model)

Editorial Board member Fernando Pérez-Ruiz analyzes recent audits on the management of gout in primary and secondary care, and suggests strategies to improve clinical practice.

Biosimilars: The price is not right

Pharmacoeconomics

Editorial Board member Marc Cohen analyzes the various economic factors influencing the price of biosimilars over recent years in rheumatology, focusing on the United States healthcare system.

20-07-2018 | Granulomatosis with polyangiitis | Editorial | Article

The ongoing evolution of remission maintenance strategies for granulomatosis with polyangiitis

Eric J Gapud and Philip Seo summarize the key milestones in management of severe granulomatosis with polyangiitis, and evaluate the possibility of long-term reduced intensity or drug-free remission for some patients.

Authors:
Eric J. Gapud, Philip Seo

22-05-2018 | Gout | Editorial | Article

Audits on gout management: Far from excellence, but working on it

Editorial Board member Fernando Pérez-Ruiz analyzes recent audits on the management of gout in primary and secondary care, and suggests strategies to improve clinical practice.

Author:
Fernando Pérez-Ruiz

22-03-2018 | Biosimilars | Editorial | Article

Biosimilars: The price is not right

Editorial Board member Marc Cohen analyzes the various economic factors influencing the price of biosimilars over recent years in rheumatology, focusing on the United States healthcare system.

Author:
Marc D Cohen

21-02-2018 | Gout | Editorial | Article

Gout therapies and cardiovascular risk

Editorial Board member Fernando Pérez-Ruiz highlights recent clinical trials evaluating the effect of febuxostat on risk of cardiovascular comorbidities, and discusses alternative treatments for gout patients with cardiovascular disease.

Author:
Fernando Pérez-Ruiz

14-02-2018 | Rheumatology nursing | Editorial | Article

The role of the clinical nurse specialist/advanced nurse practitioner in rheumatology practice: Past, present and future

Advanced nurse practitioner Patricia Minnock discusses the development of the roles of advanced nurse practitioner and clinical nurse specialist within the field of rheumatology.

Author:
Patricia Minnock

19-12-2017 | Medications | Editorial | Article

Managing antirheumatic medication in patients undergoing elective arthroplasty

Editorial Board member Oliver FitzGerald reviews the recent guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty.

Author:
Oliver FitzGerald
image credits